Determining optimal threshold for glucose control in organ donors after neurologic determination of death: A United Network for Organ Sharing Region 5 Donor Management Goals Workgroup prospective analysis

Journal of Trauma and Acute Care Surgery

Volumn 76, Issue 1, 2014, Pages 62-69

  Sally, Mitchell B ^a,b   Ewing, Tyler ^c   Crutchfield, Megan ^a   Patel, Madhukar S ^d   Raza, Shariq ^e   De La Cruz, Salvador ^a,b   Zatarain, John ^a,b   Malinoski, Darren Jay ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Donor management goals; Hyperglycemia; Transplant graft outcomes

Indexed keywords

GLUCOSE;

ADULT; BODY MASS; BRAIN DEATH; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; KIDNEY GRAFT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84892175503     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182ab0d9b     Document Type: Conference Paper

References (22)

1. The Organ Procurement and Transplantation Network. Available at: http://optn.transplant.hrsa.gov/. Accessed July 30, 2013.
2. Malinoski DJ, Patel MS, Daly MC, Oley-Graybill C, Salim A. The impact ofmeeting donormanagement goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med. 2012;40: 2773-2780.
3. Hagan ME, McClean D, Falcone CA, Arrington J, Matthews D, Summe C. Attaining specific donor management goals increases number of organs transplanted per donor: a quality improvement project. Prog Transplant. 2009;19:227-231.
4. Franklin GA, Santos AP, Smith JW, Galbraith S, Harbrecht BG, Garrison RN. Optimization of donor management goals yields increased organ use. Am Surg. 2010;76:587-594.
5. Malinoski DJ, Daly MC, Patel MS, Oley-Graybill C, Foster CE 3rd, Salim A. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma. 2011;71:990-995; discussion 996.
6. Malinoski DJ, Patel MS, Ahmed O, Daly MC, Mooney S, Graybill CO, Foster CE, Salim A. The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. Am J Transplant. 2013;13(4):993-1000.
7. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79: 992-1000.
8. Chase JG, Pretty CG, Pfeifer L, Shaw GM, Preiser JC, Le Compte AJ, Lin J, Hewett D, Moorhead KT, Desaive T. Organ failure and tight glycemic control in the SPRINT study. Crit Care. 2010;14(4):R154.
9. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, et al. Intensive versus conventional glucose control in critically ill patients.NEng JMed. 2009;360:1283-1297.
10. Salim A, MarinM,Brown C, InabaK,Roth B,Hadjizacharia P, Mascarenha A, Rhee P, Demetriades D. Using thyroid hormone in brain-dead donors to maximize the number of organs for transplant. Clin Transplant. 2007;21: 405-409.
11. Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, Niemann CU. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology. 2009;110:333-341.
12. Schetz M, Vanhorebeek I,Wouters PJ,Wilmer A, Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19(3):571-578.
13. Mehta RL. Glycemic control and critical illness: is the kidney involved? J Am Soc Nephrol. 2007;18(10):2623-2627.
14. Van den Bergh G,Woulters P,Weekers F, Verwast C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Eng J Med. 2001;345:1359-1367.
15. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Eng J Med. 2006;354:449-461.
16. Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Freire AX, GeehanD,Kohl B, Nasraway SA, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251-3276.
17. Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DE. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution's experience. Ann Surg. 1992;215:217-230.
18. Marik PE, RaghavanM. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30(5):748-756.
19. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg. 2007;73(5):454-460.
20. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc. 1997;29(8):3770-3772.
21. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobicmetabolismafter brain death, and reversal following triiodothyronine therapy. Transplantation. 1988;45(1):32-36.
22. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med. 2009;37(5):1769-1776.